- Immunokinases, a Novel Class of Immunotherapeutics for Targeted Cancer Therapy
[作者:Tur, MK; Neef, I; Jager, G; Teubner, A; Stocker, M; Melmer, G; Barth, S,期刊:Current Pharmaceutical Design, 页码:2693-2699 , 文章类型: Review,,卷期:2009年15-23]
- Certain characteristics of tumor cells make it possible to develop rational strategies for targeting tumors without harming normal cells. These include the presence of cell surface molecules that characterize the current...
- Fc gamma Receptor 1 (CD64), a Target Beyond Cancer
[作者:Thepen, T; Huhn, M; Melmer, G; Tur, MK; Barth, S,期刊:Current Pharmaceutical Design, 页码:2712-2718 , 文章类型: Review,,卷期:2009年15-23]
Immunotoxins are powerful tools to specifically eliminate deviated cells. Due to the side effects of the original immunotoxins, they were only considered for the treatment of cancer as in these cases, the potential fa...
|